4 Einträge gefunden

1. Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

   1. Hehlmann, Rüdiger
   2. Voskanyan, Astghik
   3. Lauseker, Michael
   4. Pfirrmann, Markus
   5. Kalmanti, Lida
   6. Rinaldetti, Sebastien
   7. Kohlbrenner, Katharina

   2020 - Forschungsinformationssystem des UKE
2. High-risk additional chromosomal abnormalities at low blast counts herald death by CML

   1. Hehlmann, Rüdiger
   2. Voskanyan, Astghik
   3. Lauseker, Michael
   4. Pfirrmann, Markus
   5. Kalmanti, Lida
   6. Rinaldetti, Sebastien
   7. Kohlbrenner, Katharina

   2020 - Forschungsinformationssystem des UKE
3. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

   1. Haaß, Wiltrud
   2. Kleiner, Helga
   3. Weiß, Christel
   4. Haferlach, Claudia
   5. Schlegelberger, Brigitte
   6. Müller, Martin C
   7. Hehlmann, Rüdiger

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
4. Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.

   1. Hehlmann, Rüdiger
   2. Lauseker, Michael
   3. Jung-Munkwitz, Susanne
   4. Leitner, Armin
   5. Müller, Martin C
   6. Pletsch, Nadine
   7. Proetel, Ulrike

   2011 - Forschungsinformationssystem des UKE